## TSLA: Tesla, Inc. - XLY: Consumer Cyclical

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 5.2% in lower entry zone (4.0-10.0%), top quartile (85th pct) cross-sectional ranking. Short-term MRS_5 (2.1%) confirms momentum alignment. Strong momentum (+4.9% 5-day acceleration). Outperforming sector by 4.8%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($420.48)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 3)

**1. Tesla launches low-cost Model 3 variant in Europe**
- Source: Reuters | 20251205T104200 | Neutral | Relevance: 100%
- Tesla has launched a new, lower-priced Model 3 variant in Europe to boost sales amidst intensifying competition and slowing demand. This move aims to defend Tesla's market share against cheaper rivals, particularly Chinese manufacturers, with deliveries for the new Model 3 Standard expected in the first quarter of 2026. The new variant, priced significantly lower than other Model 3 versions, offers a driving range above 300 miles despite dropping some premium features.

**2. Tesla Stock Jumps on Robotics Push and China Rebound as UK Sales Slump: TSLA Outlook for 2025–2030 (December 4, 2025)**
- Source: ts2.tech | 20251204T130859 | Neutral | Relevance: 100%
- Tesla's shares surged on December 4, 2025, driven by a White House robotics push, a significant US clean-energy grant, and a sharp rebound in China sales. This positive momentum contrasts with struggling sales in Europe, particularly a 19% year-on-year drop in the UK, and ongoing quality concerns with the Cybertruck. Analysts are divided, with some seeing short-term overvaluation but anticipating long-term growth fueled by Tesla's AI and robotics ventures.

**3. Michael Burry Says Tesla Is ‘Ridiculously Overvalued.’ Should You Ditch TSLA Stock Here?**
- Source: Barchart.com | 20251203T201000 | Bearish | Relevance: 100%
- The article discusses Michael Burry's assertion that Tesla (TSLA) is "ridiculously overvalued" due to contracting EV deliveries and significant lags in the robotaxi race. The author agrees with Burry, citing the unproven value of Tesla's robots and past failures of Elon Musk's grandiose plans. It recommends investors sell TSLA stock given the competition and the company's valuation metrics.

**4. Gains for Tesla offset drop in other 'Magnificent Seven' stocks**
- Source: MarketWatch | 20251203T182340 | Somewhat-Bullish | Relevance: 100%
- Tesla Inc. shares saw a significant climb, helping to maintain a popular exchange-traded fund tracking the "Magnificent Seven" megacap tech stocks in positive territory. This gain for Tesla offset declines experienced by several other major tech companies including Microsoft, Amazon, Nvidia, Meta Platforms, and Apple. Meanwhile, Google's parent company, Alphabet Inc., also recorded a modest increase in its stock value.

**5. Tesla Slips As Musk Says You Can Text In FSD**
- Source: Yahoo Finance | 20251205T141600 | Somewhat-Bearish | Relevance: 100%
- Tesla (NASDAQ:TSLA) shares experienced a slight dip after CEO Elon Musk suggested that texting would be permissible in cars using the latest version of Full Self-Driving (FSD Supervised). This comment sparked debate among investors and critics, as texting while driving is widely considered dangerous and illegal in many regions. The discussion also reignited conversations about the future of unsupervised FSD operation and its potential impact on traffic laws.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-25 | Mizuho | $475 | $485 | -2% |
| 2025-11-17 | Stifel | $508 | $483 | +5% |
| 2025-11-07 | Wedbush | $600 | $600 | 0% |
| 2025-11-05 | Wedbush | $600 | $600 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-25 | Mizuho | main | Outperform |
| 2025-11-17 | Stifel | main | Buy |
| 2025-11-07 | Wedbush | reit | Outperform |
| 2025-11-05 | Wedbush | reit | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($141568.60M) |
| Sells | 3 ($1.17M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 26.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Vanguard Group Inc: 7.6% (+0.4%)
- Blackrock Inc.: 6.2% (+0.4%)
- State Street Corpora: 3.4% (+0.3%)
- JPMORGAN CHASE & CO: 2.7% (+94.0%)
- Geode Capital Manage: 2.0% (+0.9%)

### Key Risks

1. High beta (1.88) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Valuation stretched: PEG 9.5x requires aggressive growth execution.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +4.9% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 9.49 signals overvaluation risk, limited margin of safety. Forward P/E 206.0x stretched relative to 35% growth. Balance sheet: strong liquidity (2.1x), $4.0B free cash flow. Insider buying signal ($141568.6M), management confidence. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $1580.4B |
| Beta | 1.88 |
| 52W Range | $214.25 - $498.83 |
| Short Interest | 2.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 9.49 |
| Forward P/E | 206.0 |
| Current P/E | 277.8 |
| YoY Growth | 34.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 0.3% to 5.2% (+4.9% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 85th percentile. MRS_5 at 2.1% confirms short-term momentum alignment. AM_20 at 7.5% shows strong absolute momentum above own 20MA. Outperforming sector by 4.8pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (5.12), confirming momentum. OFD pattern: +SUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 5.17% (CS: 86) | Strong |
| RSI_14 | 61.0 | Neutral |
| MACD Histogram | 5.12 | Bullish |
| vs SMA20 | 1.075x | Above |
| vs SMA50 | 1.045x | Above |
| vs SMA200 | 1.328x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $455.00
- **Stop Loss:** $420.48 (7.6% risk)
- **Target:** $506.78 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 28
- **Position Value:** $12,740.00
- **Portfolio %:** 12.74%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-01-28 (Est: $0.45)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.56 | $0.50 | -10.5% |
| 2025Q2 | $0.40 | $0.40 | -1.0% |
| 2025Q1 | $0.41 | $0.27 | -34.9% |
| 2024Q4 | $0.77 | $0.73 | -4.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*